Spark Biomedical

Spark Biomedical has developed a novel wearable neurostimulation platform with multiple applications. We are FDA cleared and on market to treat opioid withdrawal and addiction. We have concluded a study for neonatal opioid withdrawal syndrome and will be submitting that to the FDA next quarter. Lastly we are launching a wellness brand for Women's Menstrual health after demonstrating a 55% reduction in blood loss, 50% reduction in cramp pain, and significant improvements in mood and quality of life.